Abstract:The present study aimed to investigate the potential role of microRNA-141-3p (miR-141-3p) in chronic inflammatory pain (CIP) by targeting the high-mobility group box1 (HMGB1) gene. In the in vitro study, BV2 microglial cells were selected and assigned into blank, lipopolysaccharide (LPS), miR-141-3p mimics, mimics control, miR-141-3p inhibitor, inhibitor control, miR-141-3p mimics+LPS, mimics control+ LPS, miR-141-3p inhibitor+LPS and inhibitor control+LPS groups. Ninety-six rats were randomly divided into 8 groups (12 rats in each group): blank control, model control, negative control (NC), miR-141-3p mimics+ complete Freund’s adjuvant (CFA), mimics control+CFA, HMGB1 short hairpin RNA (shRNA)+CFA, HMGB1 NC+CFA and miR-141-3p mimics+HMGB1 shRNA+CFA groups. The quantitative real-time PCR, western blotting, enzyme-linked immunosorbent assay and pain behavioral test were used to measure the miR-141-3p and HMGB1 mRNA expressions, HMGB1 protein expression, inflammatory cytokines levels, and thermal and mechanical pain thresholds, respectively. Compared with the blank, mimics control, inhibitor control and miR-141-3p mimics+LPS groups, the miR-141-3p mimics group had increased miR-141-3p expression and interleukin (IL)-10 levels, and had decreased mRNA and protein expressions of HMGB1 and the levels of IL-1β, tumor necrosis factor-α (TNF-α) and IL-6, whereas the opposite trend were found in the LPS, miR-141-3p inhibitor, mimics control+LPS and inhibitor control+LPS groups. Compared with the LPS, miR-141-3p inhibitor, mimics control+LPS and inhibitor control+LPS groups, the miR141-3p+LPS group had an obviously decreased expression of miR-141-3p and IL-10, increased mRNA and protein expressions of HMGB1 and the levels of IL-1β, TNF-α and IL-6. Compared with the rats in the blank control group, the miR-141-3p expression, IL-10 level, and thermal and mechanical pain thresholds decreased significantly, whereas the mRNA and protein expressions of HMGB1, IL-1β, TNF-α and IL-6 increased significantly in rats in the NC, mimics control+CFA and HMGB1 NC+ CFA groups. The miR-141-3p expression was increased in rats in the miR-141-3p mimics+HMGB1 shRNA+CFA group. Our study demonstrated that miR-141-3p can alleviate the CIP by downregulating the downstream target gene HMGB1.

Overexpression of Mir-381 Relieves Neuropathic Pain Development Via Targeting HMGB1 and CXCR4.

Effect of Mirna-146A-mediated TLR4 Signal Pathway on the Pain of Lumbar Disc Herniation

Downregulation of Mir-199B Promotes the Acute Spinal Cord Injury Through IKKβ-NF-κB Signaling Pathway Activating Microglial Cells.

MiR-34c Ameliorates Neuropathic Pain by Targeting NLRP3 in a Mouse Model of Chronic Constriction Injury

Overexpression Of Mir-30a Attenuates Neuropathic Pain By Targeting Socs1 In Rats With Chronic Constriction Injury

Inhibition of miR-200b/miR-429 Contributes to Neuropathic Pain development Through Targeting Zinc finger E box binding protein-1.

Down-regulation of microRNA-382-5p reduces neuropathic pain by targeting regulation of dual specificity phosphatase-1

XIST accelerates neuropathic pain progression through regulation of miR-150 and ZEB1 in CCI rat models.

MicroRNA-128-3p Alleviates Neuropathic Pain Through Targeting ZEB1

miR-124-3p attenuates neuropathic pain induced by chronic sciatic nerve injury in rats via targeting EZH2

Downregulation of Microrna-218 Relieves Neuropathic Pain by Regulating Suppressor of Cytokine Signaling 3.

microRNA-125b-5p alleviated CCI-induced neuropathic pain and modulated neuroinflammation via targeting SOX11

Effects of Mir-150 on Neuropathic Pain Process Via Targeting AKT3.

Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies

Retracted: MicroRNA‐217 Relieved Neuropathic Pain Through Targeting Toll‐like Receptor 5 Expression

Overexpression Of miR138 Ameliorates Spared Sciatic Nerve Injury-Induced Neuropathic Pain Through The Anti-Inflammatory Response In Mice.

miR-21-5p inhibits neuropathic pain development via directly targeting C-C motif ligand 1 and tissue inhibitor of metalloproteinase-3.

Inhibition of MicroRNA-15a/16 Expression Alleviates Neuropathic Pain Development Through Upregulation of G Protein-Coupled Receptor Kinase 2

Suppression of Microrna-155 Attenuates Neuropathic Pain by Regulating Socs1 Signalling Pathway

miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1 β Pathway to Meliorate Neuropathic Pain

miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1β Pathway to Meliorate Neuropathic Pain